Dr. Tao Sun & Dr. Yehui Shi: Eribulin Combination Therapy Shines for Breast Cancer Patients, Providing More Treatment Options
Editor's Note: Breast cancer has become the most common malignant tumor globally, with approximately 30% to 40% of early-stage breast cancer patients ultimately progressing to advanced breast cancer.At this year's…
